ABOUT THE PRODUCT
IN-002 is an inhaled antibody treatment being developed as a potential treatment for respiratory syncytial virus (RSV).
Information is owner-confirmed
Last updated 1 month ago
Price range
Other products/services from Inhalon Biopharma
IN-006
Biotechnology
N/A
Inhalon Biopharma
United States (US)